## PG: Procter & Gamble Company (The) - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_20 -2.8% below STRENGTH zone (4.0-10.0%); PEG 4.21 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.6% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($140.96)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Fisher Asset Management LLC Sells 464,904 Shares of Procter & Gamble Company (The) $PG**
- Source: MarketBeat | 20251201T095348 | Somewhat-Bullish | Relevance: 99%
- Fisher Asset Management LLC reduced its stake in Procter & Gamble Company by 4.1% during the second quarter, selling 464,904 shares, but still holds over 10.9 million shares valued at approximately $1.747 billion. Procter & Gamble reported strong Q2 earnings, beating analyst estimates with an EPS of $1.99, and has an average analyst rating of "Moderate Buy" with a target price of $171.53. Insider selling occurred in the last quarter, while institutional investors maintain significant ownership of 65.77% of the stock.

**2. P&G warns US sales down ‘significantly’ entering current quarter**
- Source: Ad Age | 20251202T193800 | Neutral | Relevance: 99%
- Procter & Gamble's U.S. sales were significantly down in October, both in volume and value, according to the company's CFO. This decline marks a concerning trend as the company enters the current quarter. The article highlights P&G's domestic market performance as a key indicator.

**3. Portfolio Design Labs LLC Acquires 11,080 Shares of Procter & Gamble Company (The) $PG**
- Source: MarketBeat | 20251202T130405 | Somewhat-Bullish | Relevance: 99%
- Portfolio Design Labs LLC increased its stake in Procter & Gamble Company (The) by 40.8% in Q2, acquiring an additional 11,080 shares, bringing its total holdings to 38,207 shares valued at $6.087 million. Other institutional investors also adjusted their positions in PG stock. The article details recent insider trades, analyst ratings, and P&G's financial performance, including a recently announced quarterly dividend.

**4. Procter & Gamble's $1.5B Cost Savings Plan: Efficacy or Overreach?**
- Source: TradingView | 20251202T180731 | Neutral | Relevance: 99%
- Procter & Gamble is implementing a $1.5 billion cost savings plan to maintain profitability amid moderating consumption and rising costs, aiming to reinvest savings into brand building and R&D. The plan's large scale raises concerns about potential overreach and its impact on innovation and operational capacity, though management intends to focus cuts on non-consumer-facing areas. The article also compares P&G's strategy to those of Church & Dwight and Colgate-Palmolive, who are also employing productivity measures to counter cost pressures.

**5. Smith Moore & CO. Has $5.85 Million Position in Procter & Gamble Company (The) $PG**
- Source: MarketBeat | 20251201T121857 | Somewhat-Bullish | Relevance: 99%
- Smith Moore & CO. increased its stake in Procter & Gamble by 19.2% in Q2, now holding 36,732 shares valued at approximately $5.85 million. Insiders have been net sellers, with executives disposing of shares and total insider sales amounting to $4.61 million over the past 90 days. Procter & Gamble exceeded quarterly EPS estimates, provided strong FY-2026 guidance, and offers an attractive annual dividend yield.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 46 ($0.05M) |
| Sells | 17 ($4.90M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 32.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 10.0% (+0.6%)
- Blackrock Inc.: 7.6% (+3.8%)
- State Street Corpora: 4.3% (+0.4%)
- Geode Capital Manage: 2.6% (+2.1%)
- Morgan Stanley: 2.2% (-1.3%)

### Key Risks

1. Insider selling cluster: $4.9M in recent transactions.
2. Valuation stretched: PEG 4.2x requires aggressive growth execution.
3. Long-term trend broken: trading 8.2% below SMA200.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 4.21 signals overvaluation risk, limited margin of safety. Forward P/E 19.8x stretched relative to 5% growth. Quality metrics strong (ROE 32%, ROA 11%, margin 20%). Balance sheet: $4.2B free cash flow. Insider selling cluster ($4.9M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $327.2B |
| Beta | 0.38 |
| 52W Range | $138.14 - $179.99 |
| Short Interest | 0.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.21 |
| Forward P/E | 19.8 |
| Current P/E | 20.8 |
| YoY Growth | 5.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 0.8% to -2.8% (-3.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 6.8pp (needs >4.0% for momentum thesis). Below SMA200 (0.92x), long-term trend not supportive. RSI neutral at 42.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -2.76% (CS: 28) | Weak |
| RSI_14 | 41.9 | Neutral |
| MACD Histogram | 0.08 | Bullish |
| vs SMA20 | 0.990x | Below |
| vs SMA50 | 0.975x | Below |
| vs SMA200 | 0.918x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $145.86
- **Stop Loss:** $140.96 (3.4% risk)
- **Target:** $150.76 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 204
- **Position Value:** $29,755.44
- **Portfolio %:** 29.76%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-01-22 (Est: $1.88)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.90 | $1.99 | +4.9% |
| 2025Q2 | $1.42 | $1.48 | +4.1% |
| 2025Q1 | $1.53 | $1.54 | +0.9% |
| 2024Q4 | $1.86 | $1.88 | +1.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*